Carlyle is in talks to buy private healthcare technology firm Cotiviti Inc from Veritas Capital for up to $15bn, including debt, a person familiar with the matter said.
The private equity firm is looking to partner with another investment firm to pull off the deal, and is also in talks with direct lenders to arrange $5.5 billion of debt financing, according to the person.
If the arrangement goes through, that would be one of the largest ever direct loans, or non-bank buyout loans arranged in the private credit market, according to Bloomberg News, which first reported on the talks.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Atlanta-based Cotiviti provides payment accuracy and analytics services to health insurers and other healthcare companies.
Cotiviti, which went public in 2016, was acquired by Veritas in 2018 in a take-private deal valued at $4.9 billion, as the PE firm looked to expand its Verscend healthcare IT business.
Carlyle, Veritas and Cotiviti did not immediately respond to Reuters requests for comments.
Source: Reuters
Can’t stop reading? Read more
Carlyle backs Mecachrome with €290m financing in aerospace credit push
Carlyle backs Mecachrome with €290m financing in aerospace credit push Carlyle has committed €290m...
Invesco teams up with LGT to push private equity and credit into wealth market
Invesco teams up with LGT to push private equity and credit into wealth market Invesco has...
Welsh Carson scores IPO exit as Lumexa Imaging raises $463m in US debut
Welsh Carson scores IPO exit as Lumexa Imaging raises $463m in US debut Welsh Carson Anderson...